Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:29 PM
Ignite Modification Date:
2025-12-24 @ 10:29 PM
NCT ID:
NCT05539235
Eligibility Criteria:
Inclusion Criteria:
* age ≥50 years and meeting the diagnostic criteria for exudative AMD
* OCTA suggesting the presence of subretinal neovascularization
* no prior treatment (anti-VEGF, PDT, etc.)
* best-corrected visual acuity (BCVA) between 5-75 letters in the study eye.
Exclusion Criteria:
* allergy to drugs needed in the diagnosis and treatment
* a history of internal eye surgery (except surgery about cataract), trauma, or fundus laser photocoagulation
* other ophthalmologic diseases besides nAMD or cataracts
* renal insufficiency and severe cardiovascular and cerebrovascular diseases
* surgery required due to vitreous hemorrhage during follow-up treatment
* recent preparation for childbirth, pregnancy or lactation
* poor compliance with diagnosis and treatment or difficulty conducting a regular outpatient review and cooperating with treatment.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
55 Years
Maximum Age:
90 Years
Study:
NCT05539235
Study Brief:
Protocol Section:
NCT05539235